12-09-2022 | Medications | News
Allowing people to try out medications for type 2 diabetes and choose their preferred one is a viable approach in the absence of a clear clinical indication, say the TriMaster investigators.
12-05-2022 | SGLT2 inhibitors | News
An algorithm based on real-world clinical data could support decisions between use of SGLT2 inhibitors and DPP-4 inhibitors in people with type 2 diabetes.
11-18-2022 | Dapagliflozin | News
People who have heart failure with preserved ejection fraction benefit from dapagliflozin irrespective of whether they have normal or impaired glucose metabolism, shows further analysis of DELIVER.
02-03-2023 | Empagliflozin | News
12-20-2022 | Dapagliflozin | News
12-08-2022 | Dapagliflozin | News
12-06-2022 | Empagliflozin | News
Ian de Boer joins Amrit Lamba to discuss how these medications will influence the treatment of kidney disease in people with DKD.
10-06-2022 | SGLT2 inhibitors | News
09-02-2022 | Dapagliflozin | News
08-27-2022 | Dapagliflozin | News
08-25-2022 | Physical activity | News
08-18-2022 | Finerenone | News
06-22-2022 | SGLT2 inhibitors | News
Get the latest developments in diabetes delivered straight to your inbox
Learn about prescribing these medications with guidance from the Improving Diabetes Steering Committee.